Compare · BFLY vs CHEK
BFLY vs CHEK
Side-by-side comparison of Butterfly Network Inc. (BFLY) and Check-Cap Ltd. (CHEK): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both BFLY and CHEK operate in Medical Electronics (Health Care), so they compete in similar markets.
- BFLY is the larger of the two at $1.25B, about 58.7x CHEK ($21.3M).
- Over the past year, BFLY is up 92.9% and CHEK is up 100.6% - CHEK leads by 7.7 points.
- BFLY has hit the wire 5 times in the past 4 weeks while CHEK has been quiet.
- BFLY has more recent analyst coverage (8 ratings vs 1 for CHEK).
- Company
- Butterfly Network Inc.
- Check-Cap Ltd.
- Price
- $4.78+4.71%
- $1.61+0.63%
- Market cap
- $1.25B
- $21.3M
- 1M return
- +12.62%
- +6.62%
- 1Y return
- +92.93%
- +100.62%
- Industry
- Medical Electronics
- Medical Electronics
- Exchange
- NYSE
- NASDAQ
- IPO
- 2020
- 2015
- News (4w)
- 5
- 0
- Recent ratings
- 8
- 1
Butterfly Network Inc.
Butterfly Network, Inc., a digital health company, develops, manufactures, and commercializes ultrasound imaging solutions in the United States and internationally. It offers Butterfly iQ, a handheld and single-probe whole body ultrasound system; and Butterfly iQ+, a point-of-care ultrasound imaging device that connects with a smart phone or tablet. The company serves healthcare practitioners. Butterfly Network, Inc. was incorporated in 2011 and is headquartered in Guilford, Connecticut.
Check-Cap Ltd.
Check-Cap Ltd., a clinical stage medical diagnostics company, engages in the development of a capsule-based system that utilizes low-dose X-rays to scan the inner lining of the colon for precancerous polyps, and other structural abnormalities in Israel. Its C-Scan system consists of C-Scan Cap, an X-ray scanning capsule, which is designed to measure, collect, and transmit structural information; C-Scan Track, a disposable system attached to the patient's back via biocompatible adhesive skin patches; and C-Scan View software, a client/server-based application that enables procedure data download from the C-Scan Track, data analysis and report generation. The company was founded in 2004 and is based in Isfiya, Israel.
Latest BFLY
- Deputy General Counsel Caezza Nicholas sold $7,831 worth of shares (1,733 units at $4.52), decreasing direct ownership by 0.56% to 310,307 units (SEC Form 4) to satisfy tax liability
- Director Neubauer Caroll H was granted 73,170 shares (SEC Form 4)
- SEC Form 3 filed by new insider Neubauer Caroll H
- Butterfly Network to Participate in the William Blair 46th Annual Growth Stock Conference
- Cardiac AI Diagnostics Stack Validation Wins Across Regulatory and Commercial Fronts
- A Toronto AI-Cardiac Diagnostics Company Just Cleared Three of the Hardest Validation Bars in Medtech
- The Future of Intoxication Detection May Be in Your Voice
- Butterfly Network Inc. filed SEC Form 8-K: Leadership Update, Financial Statements and Exhibits
- Butterfly Network Appoints Caroll H. Neubauer to Board of Directors
- Butterfly Network to Present at the Bank of America Securities 2026 Global Healthcare Conference
Latest CHEK
- SEC Form 6-K filed by Check-Cap Ltd.
- SEC Form 6-K filed by Check-Cap Ltd.
- SEC Form 6-K filed by Check-Cap Ltd.
- SEC Form 6-K filed by Check-Cap Ltd.
- SEC Form 6-K filed by Check-Cap Ltd.
- MBody AI and Check-Cap Enter into Definitive Merger Agreement
- SEC Form 6-K filed by Check-Cap Ltd.
- SEC Form 6-K filed by Check-Cap Ltd.
- SEC Form 20-F filed by Check-Cap Ltd.
- Check-Cap claims BMO's Chris Taves Illegally Attacks Israeli NASDAQ-Listed Company During Wartime